Information on the target
CrestOptics S.p.A., founded in 2011 and headquartered in Rome, specializes in the development and production of advanced optical imaging systems, particularly for spinning disk confocal microscopy and super-resolution applications. The company has built a robust portfolio that includes the X-Light family of spinning disk confocal systems, the CICERO solution that integrates widefield and spinning disk microscopy, and the DeepSIM super-resolution microscopy platform. CrestOptics also provides custom optical solutions for OEM manufacturers across research, pharmaceutical, biotech, and industrial sectors, maintaining its R&D and production center in Rome.
In 2021, CrestOptics reported revenues of €6.9 million, with an EBITDA of €1.4 million and a net financial liquidity of €6.5 million. Since then, the company has achieved five consecutive years of double-digit organic revenue growth, demonstrating consistent profitability and a progressively expanding technology portfolio. The financial year 2025 concluded with a production value of €20.2 million, net revenues of €18.2 million, an EBITDA of €3 million, and a net liquidity of €1.4 million.
Industry overview in the target’s specific country
The Bio Medical Devices industry in Italy has been experiencing significant growth, driven by advancements in technology and an increasing demand for innovative healthcare solutions. Italy is recognized for its strong emphasis on research and development in the life sciences, supported by a robust network of universities and research institutions. This environment fosters innovation, enabling companies like CrestOptics to thrive in the competitive landscape of biomedical devices.
Moreover, the Italian government has been actively promoting initiatives to enhance the healthcare sector, including investments in medical technology and support for startups in the biomedical field. This has led to a surge in collaborations between private companies and public institutions, facilitating the development of cutting-edge medical devices that meet international standards.
As a result, the Italian Bio Medical Devices market is characterized by a diverse range of products, from diagnostic equipment to advanced imaging systems. The growing prevalence of chronic diseases and an aging population further drive the demand for innovative medical solutions, positioning Italy as a key player in the global biomedical landscape.
Additionally, the integration of artificial intelligence and machine learning into biomedical devices is revolutionizing the industry, enhancing diagnostic …